Strategic IP Leverage TRS's strong IP portfolio and trade secrets around 3D printed resorbable scaffolds and the Affinity mineral coating to position high-value, defensible orthopedic solutions to hospitals and surgical centers.

FDA Clear Privilege Highlight the FDA 510(k) clearance for both the scaffold technology and Affinity coating to accelerate procurement conversations with orthopedic device manufacturers and care facilities seeking compliant, proven offerings.

OEM & Acquisition Fit Target large orthopedics and spine implant players (e.g., companies with 3D printing or regenerative products) for licensing, co-development, or asset acquisition discussions given recent asset divestiture history and strong willingness to partner.

Manufacturing Readiness Promote TRS’s scalable, FDA-compliant manufacturing capability as a differentiator for high-volume production partnerships, clinical trial supply, and rapid commercialization of new scaffold and coating products.

Clinical & Research Footprint Capitalize on extensive university, NIH, and industry-sponsored validation to support business development pitches to institutions and payer stakeholders seeking evidence-backed regenerative solutions.